[go: up one dir, main page]

WO2002020498A2 - An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine - Google Patents

An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine Download PDF

Info

Publication number
WO2002020498A2
WO2002020498A2 PCT/IB2001/001615 IB0101615W WO0220498A2 WO 2002020498 A2 WO2002020498 A2 WO 2002020498A2 IB 0101615 W IB0101615 W IB 0101615W WO 0220498 A2 WO0220498 A2 WO 0220498A2
Authority
WO
WIPO (PCT)
Prior art keywords
formula
dihydro
preparation
aminothiophenol
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2001/001615
Other languages
French (fr)
Other versions
WO2002020498A3 (en
Inventor
Chandrasekhar Batchu
Om Reddy Gaddam
Rabin Bera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Research Foundation
Original Assignee
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Research Foundation filed Critical Dr Reddys Research Foundation
Priority to AU2001282403A priority Critical patent/AU2001282403A1/en
Publication of WO2002020498A2 publication Critical patent/WO2002020498A2/en
Publication of WO2002020498A3 publication Critical patent/WO2002020498A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/161,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Definitions

  • 3,4-Dihydro-l,4-benzothiazine of the formula (1) is an important intermediate / starting material for the preparation of [3,4-dihydro-l,4-benzothiazin- 4-yl]ethylmethane sulphonate of the formula (2) which in turn is a starting material for the preparation of several pharmaceutically active substances.
  • Ether was used for both reaction and extraction, which is a low boiling, highly inflammable solvent and has a poor recovery for recycling. For all practical commercial purposes it is no more used.
  • the present invention is based on our finding that the condensation of 2- aminothiophenol in polar protic solvent such as methanol, ethanol, isopropanol did not occur as this has favored the dimerization process. Similarly, the condensation of 2-aminothiophenol in polar aprotic solvents such as dimethyl formamide (DMF), N-methyl pyrrolidine (NMP) did not occur as this also favored the dimerization process. Temperatures more than 80 °C and lower than 40 °C also affects the reaction and facilitates the dimerization process.
  • polar protic solvent such as methanol, ethanol, isopropanol
  • the amounts of 2-aminothiophenol and ethyl acetate or DMF used are very specific. A ratio of 1 : 4 is used. Further increase in solvent volume may slow down the reaction rate.
  • Ethyl acetate and DMF are found to be most suitable solvents for condensation as these gave better results in terms of yields. These solvents not only addresses the problem of dimerization of the 2-aminothiophenol but also compatible with the triethylamine and ecofriendly solvents.
  • the work up involves direct filtration of the organic salt by-product and thus circumventing the tedious work up such as quenching of LAH and extraction of aqueous solution with solvents.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the preparation of 3,4-dihydro-1,4-benozthiazine of the formula (1) which comprises, condensing of 2-aminothiophenol with dihaloethane of formula (11) wherein X represents halogen atom in presence of organic base and relatively non polar solvent at a temperature in the range of 40-80 °C followed by cyclization and formation of organic salt as by product and isolating the compound of formula (1) by conventional methods.

Description

AN IMPROVED PROCESS FOR THE PREPARATION OF 3,4-DIHYDRO-
1,4-BENZOTHIAZLNE
Field of the invention
The present invention relates to an improved process for the preparation of 3,4-dihydro-l,4-benzothiazine of the formula (1).
Figure imgf000002_0001
The first synthesis of dihydrobenzothiazine was reported by Gulvenor (CA.
43, 7420 e) in the year 1949. After its first report however, the chemistry of the benzothiazine laid dormant for nearly half a century. Only during the last 5 years this class of compounds have aroused renewed interest, as evidenced by the discovery of a biologically active novel antidiabetic compounds.
3,4-Dihydro-l,4-benzothiazine of the formula (1) is an important intermediate / starting material for the preparation of [3,4-dihydro-l,4-benzothiazin- 4-yl]ethylmethane sulphonate of the formula (2) which in turn is a starting material for the preparation of several pharmaceutically active substances.
Figure imgf000002_0002
The classical method for preparation of 3,4-dihydro-l,4-benzothiazine, based upon Gulvenor (J. Chem. Soc, 278, 1949) synthesis of dihydrobenzothiazines is reaction of o-aminothiophenol (3) with ethylene oxide (4) in ethanol and potassium hydroxide under reflux conditions. The reaction is shown in Scheme- 1 below:
Figure imgf000003_0001
Scheme-1
Raffaello and Giuseppe (Gazz. Chim. ital. 81, 735, 1951) has described another method for the preparation of dihydrobenzothiazine from 2- mercaptoethanol of the formula (6) and o-chloronitrobenzene of the formula (5) using sodium and ethanol to form 2-nitrophenyl mercaptoethanol of the formula (7), which was cyclised under Nascent hydrogen evaluation generated by Tin and HC1. The reaction is shown in Scheme-2 below:
Figure imgf000003_0002
τΛs
(5) (6) (7) C1)
Scheme-2
Cymerman-Craia & Rogers (Australian J. Chem. 8, 252, 1955) has reported the synthesis of 3,4-dihydro-l,4-benzothiazine of the formula (1) and a number of substituted diphenylamines, phenothiazine and phenoselenezines for testing antihelmintic properties by a process which involves : i). reducing o-nitrophenyl disulftde of the formula (8) with H S to give o- aminophenyldisulfide of the formula (9) which on further reduction with lithium aluminium hydride (LAH) yields o-aminothiophenol of the formula (3). ii). condensation of o-aminothiophenol of the formula (3) with bromoacetic acid gave- 3,4-dihydro-3-oxo-l,4-benzothiazine of the formula (10) which on refluxing with LAH in Et2O yields 3,4-dihydro-l,4-benzothiazine of the formula (1). The reaction is shown in Scheme-3 below:
Figure imgf000004_0001
(11)
Scheme-3
Watanabe, Masanovi [(JP 02,264,768 (1990)] have reported the synthesis of
3,4-dihydro-l,4-benzothizne (1) by reacting 2-aminothiophenol (3) with 1,2- dihalogenated ethane (11) in an alcoholic solvent in presence of alkali metal carbonate and alkali metal iodide by single step cyclization. The reaction is shown in Scheme-4 below:
Figure imgf000004_0002
Scheme-4
The following disadvantages have been observed during the scale up of the above process for the preparation of the compound of the formula (1). 1. The above processes for the preparation of 3,4-dihydro-l,4-benzothiazine are very tedious and laborious.
2. The preparation starting from o-nitrothiophenol or its corresponding dimer involves use of toxic gases such as H2S.
3. • The reduction process either by metal / HC1, which generates lot of effluents or by pyrophoric reagents such as LAH, is difficult to scale up.
4. The formation of high amounts of dimer 2-aminophenyl disulfide in protic media such as alcohol with hard bases like sodium carbonate resulting in low yield of the desired product.
5. Ether was used for both reaction and extraction, which is a low boiling, highly inflammable solvent and has a poor recovery for recycling. For all practical commercial purposes it is no more used.
The present invention is based on our finding that the condensation of 2- aminothiophenol in polar protic solvent such as methanol, ethanol, isopropanol did not occur as this has favored the dimerization process. Similarly, the condensation of 2-aminothiophenol in polar aprotic solvents such as dimethyl formamide (DMF), N-methyl pyrrolidine (NMP) did not occur as this also favored the dimerization process. Temperatures more than 80 °C and lower than 40 °C also affects the reaction and facilitates the dimerization process.
Given the importance for the development of a simple, efficient and commercially practicable process for the preparation of the compound of the formula (1), we directed our research towards the development of ai r improved process for the preparation of 3,4-dihydro-l,4-benozthiazine of formula (1).
Accordingly, the main objective of the present invention is to provide an improved process for the preparation of 3,4-dihydro-l,4-benozthiazine of the formula (1).
According to a process of the present invention the compound of formula (1)
Figure imgf000006_0001
is prepared by a process which comprises : i). condensation of 2-aminothiophenol (3)
Figure imgf000006_0002
with dihaloethane of formula (11)
Figure imgf000006_0003
wherein X represents halogen atom such as chlorine, bromine, idoine or fluorine in presence of organic base and relatively non polar solvent at a temperature in the range of 40-80 °C followed by cyclization and formation of organic salt as by product and ii). isolating the compound of formula (1) by conventional methods.
This reaction is assumed to proceed through an intermediate uncyclized 2- aminophenyl-2-haloethyl sulfϊde. The reaction is solvent and temperature specific. The organic bases used for condensation are selected from diisopropylamine (DIP A), triethylamine, tributylamine, and the like. The non-polar solvent such as ethyl acetate, isopropyl acetate, butyl acetate, DMF and the like are used.
The amounts of 2-aminothiophenol and ethyl acetate or DMF used are very specific. A ratio of 1 : 4 is used. Further increase in solvent volume may slow down the reaction rate.
Preferred ratio of 2-aminothiphenol and triethylamine is 1 : 1.5 - 1.75. Any further decrease in the ratio affects the yield of the product and dimerization may take place.
The mode of addition of base to the substrate is also very important as this may lead to dimerization of the 2-aminothiophenol. The preferred way of performing the reaction is addition of triethylamine to a mixture of 2- aminothiophenol and 1,2-dibromoethane in ethylacetate.
Ethyl acetate and DMF are found to be most suitable solvents for condensation as these gave better results in terms of yields. These solvents not only addresses the problem of dimerization of the 2-aminothiophenol but also compatible with the triethylamine and ecofriendly solvents.
The work up involves direct filtration of the organic salt by-product and thus circumventing the tedious work up such as quenching of LAH and extraction of aqueous solution with solvents.
The details of the process of the present invention is described in the examples given below which are provided by way of illustration only and therefore should not be construed to limit the scope of the invention. Example - 1
Preparation of 3,4-dihydro-l,4-benzothiazine
2- Aminothiophenol (500 g), 1,2-dibromoethane (902 g, ~ 414 ml) and ethyl acetate (2 L) were taken in a 5 L 4 necked round bottom flask fitted with a mechanical stirrer, reflux condenser. The reaction mixture was slowly heated to a temperature of 55 to 65 °C under stirring and triethylamine (707 g ~968 ml) was added under nitrogen atmosphere dropwise in about 2-3 hours. As reaction progresses, the precipitation of triethylamine hydrobromide salt increases and maintained gentle reflux temperature for 10-12 h. The reaction was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to room temperature and ethyl acetate (1 L) was added for dilution of the reaction mass and ease of filtration. The precipitated solid triethylamine hydrobromide was separated by filtration. The ethyl acetate layer was washed with water (3 x 2 L), dried over Na2SO4 and concentrated on rotavapour water bath at 60-70 °C under reduced pressure. The residual crude oil was distilled under high vacuum to yield the 3,4- dihydro-l,4-benzothiazine of the formula (1) appeared as pale yellow liquid, (weight 400 g, yield 66 %, b.p (1.5 mm) 144 °C, m.p. 38 °C, purity 96-97 % by HPLC).
Example - 2
Preparation of 3,4-dihydro-l,4-benzothiazine
2-Aminothiophenol (50 g), 1,2-dichloroethane (47.5 g, ~ 38 ml) and DMF (200 ml) were taken in a 500 ml 4 necked round bottom flask fitted with a mechanical stirrer and reflux condenser. The reaction mixture was slowly heated to a temperature of 55 to 65 °C under stirring and triethylamine (70.7 g, -96.8 ml) was added under nitrogen atmosphere dropwise in about 2-3 hours. As reaction progresses, the precipitation of triethylamine hydrochloride salt increases and maintained gentle reflux temperature for 10-12 h. The reaction was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to room temperature and ethyl acetate (1 L) was added for dilution of the reaction mass and ease of filtration. The precipitated solid triethylamine hydrochloride was separated by filtration. The ethyl acetate layer was washed with water (3 x 200 ml), dried over Na2SO4 and concentrated on rotavapour water bath at 60-70 °C under reduced pressure. The residual dark orange colored crude oil was distilled under high vacuum to yield the 3,4-dihydro-l,4-benzothiazine appeared as pale yellow liquid, (weight 24 g, yield 40 %, b.p (1.5 mm) 144 °C, m.p. 38 °C, purity 96 % by HPLC).
Example - 3
Preparation of 3,4-dihydro-l,4-benzothiazine
2-Aminothiophenol (50 g), l-bromo-2-chloroethane (68.6 g, ~ 40 ml) and DMF (200 ml) were taken in a 500 ml 4 necked round bottom flask fitted with a mechanical stirrer and reflux condenser. The reaction mixture was slowly heated to a temperature of 55 to 65 °C under stirring and triethylamine (70.7 g, 96.8 ml) was added under nitrogen atmosphere dropwise in about 2-3 hours. As reaction progresses, the precipitation of triethylamine salt increases and maintained gentle reflux temperature for 10-12 h. The reaction was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to room temperature and ethyl acetate (1 L) was added for dilution of the reaction mass and ease of filtration. The precipitated solid triethylamine salt was separated by filtration. The ethyl acetate layer was washed with water (3 x 200 ml), dried over Na2SO4 and concentrated on rotavapour water bath at 60-70 °C under reduced pressure. The residual dark orange colored crude oil was distilled under high vacuum to yield the 3,4-dihydro-l,4-benzothiazine appeared as pale yellow liquid, (weight 30 g, yield 50 %, b.p (1.5 mm) 144 °C, m.p. 38 °C, purity 96 % by HPLC). The following are the advantages of the present invention :
1. A convenient synthesis of the compound of the formula (1) has been developed without extraction.
2. The process is very simple and efficient with safe operation.
3. The use of ethyl acetate as medium has addressed the problem of dimerization of the 2-aminothiophenol, thus improving the overall yield and purity of the product.

Claims

Claims : l.A process for the preparation of 3,4-dihydro-l,4-benozthiazine of the formula (1).
Figure imgf000011_0001
which comprises, i). condensing the 2-aminothiophenol of the formula (3)
Figure imgf000011_0002
with dihaloethane of formula (11)
Figure imgf000011_0003
wherein X represents halogen atom in the presence of organic base and relatively non polar solvents at a temperature in the range of 40-80 °C followed by cyclization and formation of organic salt as by product and ii). isolating the compound of formula (1) by conventional methods.
2. The process as claimed in claim 1, wherein the organic base used for condensation is selected from diisopropylamine, triethylamine or tributylamine.
3. The process as claimed in claims 1 and 2, wherein the non-polar solvent used is selected from ethyl acetate, isopropyl acetate, butyl acetate or DMF.
4. The process as claimed in claims 1 to 3, wherein the amount of 2- aminothiophenol and ethyl acetate or DMF used is in the ratio of 1 : 4.
5. The process as claimed in claims 1 to 4, wherein the amount of 2- aminothiphenol and triethylamine used is in the ration of 1 : 1.5 - 1.75.
6. The process for the preparation of 3,4-dihydro-l,4-benozthiazine of the formula (1) substantially as herein described with reference to the examples.
PCT/IB2001/001615 2000-09-04 2001-09-03 An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine Ceased WO2002020498A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001282403A AU2001282403A1 (en) 2000-09-04 2001-09-03 An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN719/MAS/2000 2000-09-04
IN719MA2000 2000-09-04

Publications (2)

Publication Number Publication Date
WO2002020498A2 true WO2002020498A2 (en) 2002-03-14
WO2002020498A3 WO2002020498A3 (en) 2002-08-15

Family

ID=11097185

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001615 Ceased WO2002020498A2 (en) 2000-09-04 2001-09-03 An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine

Country Status (2)

Country Link
AU (1) AU2001282403A1 (en)
WO (1) WO2002020498A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7305432B2 (en) 2002-10-23 2007-12-04 Aol Llc Privacy preferences roaming and enforcement
US10467551B2 (en) 2017-06-12 2019-11-05 Ford Motor Company Portable privacy management

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7290278B2 (en) 2003-10-02 2007-10-30 Aol Llc, A Delaware Limited Liability Company Identity based service system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02264768A (en) * 1989-04-04 1990-10-29 Ube Ind Ltd Production of 3,4-dihydro-1,4-benzothiazines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 114, no. 15, 15 April 1991 (1991-04-15) Columbus, Ohio, US; abstract no. 143434, WATANABE M.: "Preparation of 3,4-dihydro-1,4-benzothiazine derivatives" XP002187711 & JP 02 264768 A (UBE IND. LTD.) 29 October 1990 (1990-10-29) cited in the application *
J. L. LENG: "Synthesis and reactivity of 4-substituted-2,3-dihydrobenzo-1,4-thiazin es" JOURNAL OF HETEROCYCLIC CHEMISTRY., vol. 19, no. 2, 1982, pages 237-240, XP002187710 HETEROCORPORATION. PROVO., US ISSN: 0022-152X *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7305432B2 (en) 2002-10-23 2007-12-04 Aol Llc Privacy preferences roaming and enforcement
US10467551B2 (en) 2017-06-12 2019-11-05 Ford Motor Company Portable privacy management

Also Published As

Publication number Publication date
WO2002020498A3 (en) 2002-08-15
AU2001282403A1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
US9611225B2 (en) Process for preparation of androgen receptor antagonist
US6822119B1 (en) Process for the preparation of tolterodine
EP1138677B1 (en) Process for the preparation of 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepine and application to the synthesis of tianeptine
US10836730B2 (en) Process for preparation and purification of vortioxetine hydrobromide
US6407255B2 (en) Chemical synthesis of 1,2,4-triazolinone derivative
WO2002020498A2 (en) An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine
US20070123573A1 (en) Process for the preparation of biologically active tetrahydrobenzthiazole derivative
IL182439A (en) Intermediates useful for the preparation of aripiprazole and methods for the preparation of the intermediates and aripiprazole
US8222408B2 (en) Process for preparing acyl amide compounds
US20070260061A1 (en) Preparation Of 9-Hydroxy -(2-Hydroxyethyl)-2-Methyl-4H-Pyrido[1,2-A]Pryimidin-4-One
US6197969B1 (en) Process for producing substituted alkylamines or salts thereof
US8044196B2 (en) Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
RU2249592C2 (en) Method for production of pyrlindone hydrochloride
US7619095B2 (en) Process for the preparation of indolone derivative
CN1197866C (en) 4,6-dihydrofuran [3,4-d] imidazole-6- ketone derivative and salt and preparation method thereof
NO147838B (en) INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE
KR0171221B1 (en) N-2-chlorobenzyl-2-oxo and n-2-chlorobenzyl-2,2-dioxo-1,2,3-oxahiazolidine derivatives, their preparation method and the method preparing thieno[3,2-c]pyridine derivatives synthesized therefrom
CN117285479B (en) Preparation method of 3-chloro-5, 5-dimethyl-4, 5-dihydro-isoxazole
EP0009284A1 (en) Novel tetracyclic compounds, processes for their preparation and pharmaceutical compositions
NO882085L (en) CYKLOBUTENMELLOMPRODUKT.
US20250263414A1 (en) An improved process for the preparation of remimazolam
US7132549B2 (en) Process
US20220194977A1 (en) New process for preparing sugammadex
WO2002040460A1 (en) A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate
KR19990015050A (en) Method for preparing phenylpropionic acid derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP